文献速递眼整形与眼眶眼底病与葡萄膜炎

IgG4相关眼病三例报告

[IgG4-related ophthalmic disease: three-case report].
PubMed 文献 · Zhonghua Yan Ke Za Zhi · 2021-01-01

三例男性IgG4相关眼病患者均双眼受累并伴眶外组织受累,表现为泪腺肿大伴球结膜水肿或眼睑肿胀。经糖皮质激素冲击治疗后症状均好转,随访58至60个月,其中2例复发1次、1例复发3次。

要点

  • 三例均为男性,双眼受累且伴眶外组织受累,诊断为IgG4相关眼病。
  • 糖皮质激素冲击治疗后三例症状均好转。
  • 随访58至60个月,2例复发1次、1例复发3次。

核心结论

  • 三例男性IgG4相关眼病患者经糖皮质激素冲击治疗后症状均好转,但随访期间均出现复发。

研究设计与样本

  • 三例病例报告,来源为中华眼科杂志2021年57卷375至378页。

主要发现

  • 三例均为男性,眼部检查均为双眼受累。
  • 2例表现为双眼泪腺肿大伴有球结膜水肿,1例为双眼眼睑肿胀。
  • 三例均伴有眶外组织受累,均诊断为IgG4相关眼病。
  • 经糖皮质激素冲击治疗后患者症状均好转,分别随访58、54、60个月。
  • 随访期间2例患者复发1次,1例患者复发3次。

临床怎么用

  • 对双眼受累并伴眶外组织受累的男性患者,应考虑IgG4相关眼病的诊断。
  • 糖皮质激素冲击治疗可改善IgG4相关眼病症状,但需长期随访监测复发。

局限性

  • 仅为三例病例报告,样本量小,无法提供疗效或复发的群体层面估计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The first patient complained visual loss of left eye for 1 week. The second patient complained visual loss of right eye for 2 months with conjunctival edema for more than 10 days. The third patient complained redness and swelling of both eyes for 1 year, poor appetite and fatigue for 4 months. All three patients were male with binocular involvement. Enlargement of lacrimal glands in both eyes with bulbar conjunctival edema were observed in 2 patients and binocular eyelid swelling in 1 patient, all 3 patients were associated with external orbital tissue involvement, which were diagnosed as IgG4-related ophthalmic diseases. After treatment with glucocorticoid, the symptoms of the patients were improved, and the patients were followed up for 58, 54, and 60 months, respectively. Among the 3 patients, 2 had recurrence for once, and 1 had recurrence 3 for times. (Chin J Ophthalmol, 2021, 57: 375-378). 1例主诉为左眼视力下降1周;1例主诉为右眼视力减退2个月、结膜水肿10余天;1例主诉为双眼红肿1年,纳差、乏力4个月患者分别就诊眼科。3例患者均为男性,眼部检查均为双眼受累,2例表现为双眼泪腺肿大伴有球结膜水肿,1例为双眼眼睑肿胀,3例均伴有眶外组织受累,均诊断为IgG4相关眼病。经糖皮质激素冲击治疗后患者症状均好转,分别随访58、54、60个月,其中2例患者复发1次,1例患者复发3次。(中华眼科杂志,2021,57:375-378).

来源:Zhonghua Yan Ke Za Zhi,查看原文。版权归原作者所有。

引用

  1. Cao SS, Zhou HF, Wei SH, et al. [IgG4-related ophthalmic disease: three-case report]. Zhonghua Yan Ke Za Zhi. 2021. PMID: 33915642. doi:10.3760/cma.j.cn112142-20200917-00599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。